Enhancement of osteogenic gene expression for the differentiation of human periosteal derived cells

Stem Cell Research

Volumn 7, Issue 2, 2011, Pages 137-144

  Roberts, Scott J ^a   Chen, Yantian ^a   Moesen, Maarten ^a   Schrooten, Jan ^a   Luyten, Frank P ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BOVINE SERUM ALBUMIN; CALCITRIOL; CYCLIC AMP; DEXAMETHASONE; RETINOIC ACID;

ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL POPULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; OSTEOBLAST; PERIOSTEUM; PRIORITY JOURNAL;

ADOLESCENT; ANIMALS; CATTLE; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; OSTEOBLASTS; OSTEOGENESIS; STEM CELLS; YOUNG ADULT;

ATRA; BOVINAE;

EID: 79960309216     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2011.04.003     Document Type: Article

References (32)

1. Arutyunyan I.V., Rzhaninova A.A., Volkov A.V., Goldstein D.V. Effect of dexamethasone on differentiation of multipotent stromal cells from human adipose tissue. Bull. Exp. Biol. Med. 2009, 147:503-508.
2. Benayahu D., Fried A., Shamay A., Cunningham N., Blumberg S., Wientroub S. Differential effects of retinoic acid and growth factors on osteoblastic markers and CD10/NEP activity in stromal-derived osteoblasts. J. Cell. Biochem. 1994, 56:62-73.
3. Box G.E.P., Hunter W.G., Hunter J.S. Statistics for Experimenters 1978, John Wiley and Sons, New York.
4. Chai, Y.C., Roberts, S.J., Schrooten, J., Luyten, F.P., 2011. Probing the osteoinductive effect of calcium phosphate by using an in-vitro biomimetic model. Tissue Eng. Part A 17, 1083-1097.
5. Ducy P., Starbuck M., Priemel M., Shen J., Pinero G., Geoffroy V., Amling M., Karsenty G. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 1999, 13:1025-1036.
6. Frendo J.L., Xiao G., Fuchs S., Franceschi R.T., Karsenty G., Ducy P. Functional hierarchy between two OSE2 elements in the control of osteocalcin gene expression in vivo. J. Biol. Chem. 1998, 273:30509-30516.
7. Hong J.H., Hwang E.S., McManus M.T., Amsterdam A., Tian Y., Kalmukova R., Mueller E., Benjamin T., Spiegelman B.M., Sharp P.A., Hopkins N., Yaffe M.B. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 2005, 309:1074-1078.
8. Jaiswal N., Haynesworth S.E., Caplan A.I., Bruder S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell. Biochem. 1997, 64:295-312.
9. James, A.W., Levi, B., Xu, Y., Carre, A.L., Longaker, M.T., 2010. Retinoic acid enhances osteogenesis in cranial suture-derived mesenchymal cells: potential mechanisms of retinoid-induced craniosynostosis. Plast. Reconstr. Surg. 125, 1352-1361.
10. Kaji H., Sugimoto T., Kanatani M., Kano J., Fukase M., Chihara K. Effect of retinoic acid on the proliferation and alkaline phosphatase activity of osteoblastic MC3T3-E1 cells by modulating the release of local regulators from monocytes. Exp. Clin. Endocrinol. Diabetes 1995, 103:297-302.
11. Karner E., Backesjo C.M., Cedervall J., Sugars R.V., Ahrlund-Richter L., Wendel M. Dynamics of gene expression during bone matrix formation in osteogenic cultures derived from human embryonic stem cells in vitro. Biochim. Biophys. Acta 2009, 1790:110-118.
12. Komori T. Regulation of bone development and maintenance by Runx2. Front. Biosci. 2008, 13:898-903.
13. Kosaka C., Sasaguri T., Komiyama Y., Takahashi H. All-trans retinoic acid inhibits vascular smooth muscle cell proliferation targeting multiple genes for cyclins and cyclin-dependent kinases. Hypertens. Res. 2001, 24:579-588.
14. Lee M.H., Kwon T.G., Park H.S., Wozney J.M., Ryoo H.M. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem. Biophys. Res. Commun. 2003, 309:689-694.
15. Lian J.B., Shalhoub V., Aslam F., Frenkel B., Green J., Hamrah M., Stein G.S., Stein J.L. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression. Endocrinology 1997, 138:2117-2127.
16. Liu P., Oyajobi B.O., Russell R.G., Scutt A. Regulation of osteogenic differentiation of human bone marrow stromal cells: interaction between transforming growth factor-beta and 1,25(OH)(2) vitamin D(3) In vitro. Calcif. Tissue Int. 1999, 65:173-180.
17. McCulloch C.A., Tenenbaum H.C. Dexamethasone induces proliferation and terminal differentiation of osteogenic cells in tissue culture. Anat. Rec. 1986, 215:397-402.
18. Ogston N., Harrison A.J., Cheung H.F., Ashton B.A., Hampson G. Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics. Steroids 2002, 67:895-906.
19. Oshina H., Sotome S., Yoshii T., Torigoe I., Sugata Y., Maehara H., Marukawa E., Omura K., Shinomiya K. Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells. Bone 2007, 41:575-583.
20. Rickard D.J., Sullivan T.A., Shenker B.J., Leboy P.S., Kazhdan I. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev. Biol. 1994, 161:218-228.
21. Roberts S.J., Geris L., Kerckhofs G., Desmet E., Schrooten J., Luyten F.P. The combined bone forming capacity of human periosteal derived cells and calcium phosphates. Biomaterials 2011, 32:4393-4405.
22. Schepmoes G., Breen E., Owen T.A., Aronow M.A., Stein G.S., Lian J.B. Influence of dexamethasone on the vitamin D-mediated regulation of osteocalcin gene expression. J. Cell. Biochem. 1991, 47:184-196.
23. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3:1101-1108.
24. Siddappa R., Martens A., Doorn J., Leusink A., Olivo C., Licht R., van Rijn L., Gaspar C., Fodde R., Janssen F., van Blitterswijk C., de Boer J. cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7281-7286.
25. Smith E., Redman R.A., Logg C.R., Coetzee G.A., Kasahara N., Frenkel B. Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes. J. Biol. Chem. 2000, 275:19992-20001.
26. Song I.H., Caplan A.I., Dennis J.E. In vitro dexamethasone pretreatment enhances bone formation of human mesenchymal stem cells in vivo. J. Orthop. Res. 2009, 27:916-921.
27. Turksen K., Aubin J.E. Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells. J. Cell Biol. 1991, 114:373-384.
28. Uchida A., Kikuchi T., Shimomura Y. Osteogenic capacity of cultured human periosteal cells. Acta Orthop. Scand. 1988, 59:29-33.
29. Ulsamer A., Ortuno M.J., Ruiz S., Susperregui A.R., Osses N., Rosa J.L., Ventura F. BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38. J. Biol. Chem. 2008, 283:3816-3826.
30. Viereck V., Siggelkow H., Tauber S., Raddatz D., Schutze N., Hufner M. Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts. J. Cell. Biochem. 2002, 86:348-356.
31. Wan D.C., Shi Y.Y., Nacamuli R.P., Quarto N., Lyons K.M., Longaker M.T. Osteogenic differentiation of mouse adipose-derived adult stromal cells requires retinoic acid and bone morphogenetic protein receptor type IB signaling. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:12335-12340.
32. Zilberberg L., ten Dijke P., Sakai L.Y., Rifkin D.B. A rapid and sensitive bioassay to measure bone morphogenetic protein activity. BMC Cell Biol. 2007, 8:41.